Real-world effectiveness of the heterologous SOBERANA-02 and SOBERANA-Plus vaccine scheme in 2-11 years-old children during the SARS-CoV-2 Omicron wave in Cuba: a longitudinal case-population studyResearch in context

• Main Authors: María Eugenia Toledo-Romaní (Author), Carmen Valenzuela-Silva (Author), Minerva Montero-Díaz (Author), Luisa Iñiguez-Rojas (Author), Meiby Rodríguez-González (Author), Mery Martínez-Cabrera (Author), Rinaldo Puga-Gómez (Author), Angel German-Almeida (Author), Sonsire Fernández-Castillo (Author), Yanet Climent-Ruiz (Author), Darielys Santana-Mederos (Author), Lissette López-González (Author), Ileana Morales-Suárez (Author), Delaram Doroud (Author), Yury Valdés-Balbín (Author), Dagmar García-Rivera (Author), Patrick Van der Stuyft (Author), Vicente Vérez-Bencomo (Author)
• Format: Book
• Published: Elsevier, 2024-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: Increased pediatric COVID-19 occurrence due to the SARS-CoV-2 Omicron variant has raised concerns about the effectiveness of existing vaccines. The protection provided by the SOBERANA-02-Plus vaccination scheme against this variant has not yet been studied. We aimed to evaluate...